Skip to main content
Glama

Rxnorm

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool as read-only, idempotent, and non-destructive, and the description adds substantial behavioral detail beyond that: parallel fan-out across sources, soft-fail behavior for the USPTO patents sunset, expected-empty sections like fda_products, resolved:false handling for private companies, and the semantics of sources_used/sources_failed.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but every clause carries operational weight—input forms, output fields, source failures, and edge cases. It is front-loaded with the primary purpose and usage rule, and the rest of the detail is directly actionable rather than filler.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description correctly takes on the burden of explaining return values. It enumerates all major output sections and their semantics, explains failure modes, covers the no-data-versus-bug distinction, and describes all valid input shapes. An agent has everything needed to select and call this tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description adds meaningful value: it documents zero-padded CIK formatting, gives concrete examples for ticker/CIK/name, and clarifies that type accepts 'company' or 'ticker' interchangeably with identical behavior. These are operational details an agent needs beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific action: it produces a full cross-source profile of a US public company in one parallel call, supported by example user phrasings and a concrete list of what the tool returns. It also differentiates itself from single-source lookups by name ('ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups'), making its purpose unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says to prefer this tool when the user asks for a holistic view, rather than chaining separate single-source lookups. It does not explicitly discuss when to prefer sibling tools like compare_entities or resolve_entity, but the main usage rule is clear enough for most routing decisions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Rxnorm toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several tools blur together: ask_pipeworx_beta currently duplicates ask_pipeworx exactly, ask_pipeworx/ask_pipeworx_grounded/deep_research/validate_claim all route natural-language questions to data sources, and the prediction-market tools (polymarket_edges, polymarket_arbitrage, polymarket_fill_risk, bet_research) have fuzzy boundaries. The detailed descriptions help, but an agent can easily misselect among them.

Naming Consistency3/5

All names are lowercase snake_case and the rxnorm_, polymarket_, and pipeworx_ prefixes create readable groupings, but the set mixes imperative verb-object names (validate_claim, list_subscriptions), noun-phrase names (entity_profile, recent_alerts), and bare verbs (remember, forget). It is readable but not a predictable uniform naming convention.

Tool Count2/5

35 tools is in the too-many band for a coherent server, and the Rxnorm identity makes it worse: only 4 tools are actually RxNorm-specific while 31 are unrelated Pipeworx, prediction-market, memory, and utility tools. A focused RxNorm server would need a fraction of this surface.

Completeness3/5

The four rxnorm_* tools plus resolve_entity cover the main RxNorm lookup flow (search, properties, related, NDC), so the core is not broken. But the set lacks a reverse NDC-to-concept lookup and the 31 non-RxNorm tools do not complete any single coherent domain, leaving notable gaps relative to the server's stated purpose.

Resources